Nephros Schedules Q1 2026 Earnings Call for May 7

PRISM MediaWire reports that Nephros, Inc. (Nasdaq: NEPH), a leading water technology company specializing in filtration solutions for medical and commercial markets, has announced the schedule for its first-quarter 2026 financial results. The company will release its earnings after market close on Thursday, May 07, 2026, followed by a conference call at 4:30pm ET. Investors can participate by dialing 1 (844) 808-7106 for domestic access or 1 (412) 317-5285 for international access, and asking to be joined into the Nephros conference call. An audio archive will be available on the Nephros Investor Relations page shortly after the call, and a replay can be accessed until May 14, 2026, by calling 1-855-669-9658 or 1-412-317-0088 with replay access code 1329051.

Nephros is committed to improving the human relationship with water through leading, accessible technology. The company provides innovative water filtration products and services, along with water-quality education, as part of an integrated approach to water safety. Their goods serve customers in medical and commercial markets, offering both proactive and emergency solutions for water management. Key executives include CEO Robert Banks and investor relations contact Kirin Smith of PCG Advisory, Inc. For more information about Nephros, visit nephros.com. The latest news and updates relating to $NEPH are available in the company’s newsroom at tinyurl.com/nephnewsroom.

This announcement is crucial for investors and stakeholders tracking Nephros's financial performance and strategic direction. The first-quarter results will provide insights into the company's growth trajectory, particularly in the medical and commercial water filtration sectors. Given the increasing importance of water safety and quality, Nephros's innovations in filtration technology position it as a key player in addressing global water challenges. The conference call offers a direct opportunity for analysts and shareholders to engage with management and assess the company's outlook.